{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:37:06Z","timestamp":1762972626841,"version":"3.45.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T00:00:00Z","timestamp":1762905600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>This study evaluates the efficacy and safety of emulsified microsomal Ferric pyrophosphate (EMFP\/SunActive\u2122 Fe, 27\u00a0mg elemental iron) versus Ferrous Ascorbate (100\u00a0mg elemental iron) in second-trimester pregnant women with iron-deficiency anemia (IDA) for 4 weeks. Pregnant women aged 20\u201335 years with a singleton pregnancy, hemoglobin (Hb) 9\u201310.5\u00a0g\/dL, and ferritin\u2009&lt;\u200915 mcg\/L were enrolled. The test group showed zero adverse effects vs. the control group, having 11.1% adverse events. The gastrointestinal(GI) adverse symptoms, including nausea, dark stools, and hyperacidity, were reported only in the Ferrous Ascorbate group, indicating superior tolerability and safety of EMFP tablets. Both groups showed similar improvements in Hb (\u03942.63\u00a0g\/dL vs. \u03942.62\u00a0g\/dL) and serum ferritin (61.09% vs. 61.92%). Reticulocyte hemoglobin (RET-He) increased by 20.5% in the test group and 16.2% in the control group, with no significant difference. Clinical symptoms such as dizziness, fatigue, and palpitations improved with greater magnitude in the test group. It was inferred that the test group receiving EMFP was as effective as the control group in improving efficacy endpoints at a significantly lower dose (1\/3rd dose compared to ascorbate). EMFP showed better tolerability, safety and compliance, making it a promising option for managing IDA in pregnant women.<\/jats:p>","DOI":"10.1038\/s41598-025-23353-9","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:32:22Z","timestamp":1762972342000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy and safety of emulsified microsomal ferric pyrophosphate vs. Ferrous Ascorbate in pregnancy with iron-deficiency anemia- a randomized, comparative study"],"prefix":"10.1038","volume":"15","author":[{"given":"Ameet","family":"Patki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. S.","family":"Jyothi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vidya","family":"Thobbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ankita","family":"Srivastav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayatri","family":"Ganu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alok S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,12]]},"reference":[{"key":"23353_CR1","unstructured":"WHO |Anemia. WHO [Internet]. [cited 2021 Dec 21]. (2019). Available from: https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/anaemia_in_women_and_children"},{"key":"23353_CR2","unstructured":"https:\/\/www.who.int\/health-topics\/anaemia"},{"key":"23353_CR3","doi-asserted-by":"publisher","first-page":"847693","DOI":"10.3389\/fnut.2022.847693","volume":"9","author":"R Rahman","year":"2022","unstructured":"Rahman, R., Idris, I. B., Isa, Z. M., Rahman, R. A. & Mahdy, Z. A. The prevalence and risk factors of iron deficiency anemia among pregnant women in malaysia: A systematic review. Front. Nutr. 9, 847693. https:\/\/doi.org\/10.3389\/fnut.2022.847693 (2022).","journal-title":"Front. Nutr."},{"issue":"1","key":"23353_CR4","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1186\/s12889-024-17789-3","volume":"24","author":"S Let","year":"2024","unstructured":"Let, S., Tiwari, S., Singh, A. & Chakrabarty, M. Prevalence and determinants of anaemia among women of reproductive age in aspirational districts of india: an analysis of NFHS 4 and NFHS 5 data. BMC Public. Health. 24 (1), 437. https:\/\/doi.org\/10.1186\/s12889-024-17789-3 (2024).","journal-title":"BMC Public. Health"},{"issue":"1","key":"23353_CR5","doi-asserted-by":"publisher","first-page":"e21444","DOI":"10.7759\/cureus.21444","volume":"14","author":"S Kaushal","year":"2022","unstructured":"Kaushal, S., Priya, T. & Thakur, S. The etiology of anemia among pregnant women in the hill state of Himachal Pradesh in North india: A Cross-Sectional study. Cureus 14 (1), e21444. https:\/\/doi.org\/10.7759\/cureus.21444 (2022).","journal-title":"Cureus"},{"issue":"8","key":"23353_CR6","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1182\/blood-2016-08-672246","volume":"129","author":"M Maureen","year":"2017","unstructured":"Maureen, M. & Achebe Anat Gafter-Gvili; how I treat anemia in pregnancy: iron, cobalamin, and folate. Blood 129 (8), 940\u2013949. https:\/\/doi.org\/10.1182\/blood-2016-08-672246 (2017).","journal-title":"Blood"},{"issue":"5","key":"23353_CR7","doi-asserted-by":"publisher","first-page":"e166","DOI":"10.5001\/omj.2020.108","volume":"35","author":"S Garzon","year":"2020","unstructured":"Garzon, S. et al. Iron deficiency anemia in pregnancy: novel approaches for an old problem. Oman Med. J. 35 (5), e166. https:\/\/doi.org\/10.5001\/omj.2020.108 (2020).","journal-title":"Oman Med. J."},{"key":"23353_CR8","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.18203\/2320-1770.ijrcog20231543","volume":"12","author":"MM Anadkat","year":"2023","unstructured":"Anadkat, M. M. & Goswami, K. D. A study of fetomaternal outcome in cases of severe anemia in labor at a tertiary care center. Int. J. Reprod. Contracept. Obstet. Gynecol. 12, 1721\u20131724 (2023).","journal-title":"Int. J. Reprod. Contracept. Obstet. Gynecol."},{"issue":"3","key":"23353_CR9","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1111\/bcp.15078","volume":"88","author":"G Culeddu","year":"2022","unstructured":"Culeddu, G. et al. Novel oral iron therapy for iron deficiency anaemia: how to value safety in a new drug? Br. J Clin. Pharmacol. 88 (3), 1347\u20131357. https:\/\/doi.org\/10.1111\/bcp.15078 (2022).","journal-title":"Br. J Clin. Pharmacol"},{"key":"23353_CR10","doi-asserted-by":"publisher","first-page":"846824","DOI":"10.1100\/2012\/846824","volume":"2012","author":"P Santiago","year":"2012","unstructured":"Santiago, P. Ferrous versus ferric oral iron formulations for the treatment of iron deficiency: a clinical overview. Sci. World J. 2012, 846824. https:\/\/doi.org\/10.1100\/2012\/846824 (2012). Epub 2012 May 2.","journal-title":"Sci. World J."},{"issue":"8","key":"23353_CR11","doi-asserted-by":"publisher","first-page":"991e1","DOI":"10.1016\/j.amjmed.2017.03.045","volume":"130","author":"MM Okam","year":"2017","unstructured":"Okam, M. M. et al. Iron Supplementation, response in Iron-Deficiency anemia: analysis of five trials. Am. J. Med. 130 (8), 991e1\u2013991e8 (2017).","journal-title":"Am. J. Med."},{"key":"23353_CR12","unstructured":"[Updated. Aug 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2022 Jan-. (2021). Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK448065\/"},{"issue":"3","key":"23353_CR13","doi-asserted-by":"publisher","first-page":"e57108","DOI":"10.7759\/cureus.57108","volume":"16","author":"A Srivastav","year":"2024","unstructured":"Srivastav, A., Kshirsagar, S., Adhav, T., Ganu, G. & Shah, A. Efficacy and safety of microsomal ferric pyrophosphate supplement for iron deficiency anemia in pregnancy. Cureus 16 (3), e57108. https:\/\/doi.org\/10.7759\/cureus.57108 (2024).","journal-title":"Cureus"},{"issue":"1","key":"23353_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","volume":"116","author":"A des Rieux","year":"2006","unstructured":"des Rieux, A., Fievez, V., Garinot, M., Schneider, Y. & Pr\u00e9at, V. Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach. J. Controlled Release. 116 (1), 1\u201327. https:\/\/doi.org\/10.1016\/j.jconrel.2006.08.013 (2006).","journal-title":"J. Controlled Release"},{"issue":"11","key":"23353_CR15","first-page":"94","volume":"10","author":"A Srivastav","year":"2023","unstructured":"Srivastav, A., Pendse, S., Palahe, P. & Shah, A. Particle size matters: A comparative study of transport of encapsulated iron through M cells. Int. J. Sci. Stud. 10 (11), 94\u201399 (2023).","journal-title":"Int. J. Sci. Stud."},{"issue":"2","key":"23353_CR16","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1024\/0300-9831.78.2.74","volume":"78","author":"N Angeles-Agdeppa","year":"2008","unstructured":"Angeles-Agdeppa, N., Capanzana, N., Barba, N., Florentino, N. & Takanashi, N. Efficacy of Iron-Fortified rice in reducing anemia among schoolchildren in the Philippines. Int. J. Vitam. Nutr. Res. 78 (2), 74\u201386. https:\/\/doi.org\/10.1024\/0300-9831.78.2.74 (2008).","journal-title":"Int. J. Vitam. Nutr. Res."},{"key":"23353_CR17","unstructured":"Allen, L., Bruno de Benoist, O. & Hurrell, R. (eds) Dary,. Guidelines on food fortification with micronutrients. In Food and Agricultural Organization of the United Nations & World Health Organization, Food and Agricultural Organization of the United Nations. (2006). https:\/\/iris.who.int\/bitstream\/handle\/10665\/43412\/9241594012_eng.pdf"},{"issue":"11","key":"23353_CR18","first-page":"3602","volume":"22","author":"AS Lagan\u00e0","year":"2018","unstructured":"Lagan\u00e0, A. S. et al. Effects of micronised dispersible ferric pyrophosphate combined with alpha-lactalbumin in pregnant women affected by iron deficiency anemia: results from a prospective, double-blind, randomised controlled trial. Eur. Rev. Med. Pharmacol. Sci. 22 (11), 3602\u20133608 (2018). doi: 10.26355\/eurrev_201806_15187. PMID: 29917215.","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"23353_CR19","doi-asserted-by":"publisher","unstructured":"Angelucci, M. A novel combination of alpha-lactalbumin and iron for the management of iron-deficiency anemia in women with menometrorrhagia: a pilot study. IJMDAT 3 (e246). https:\/\/doi.org\/10.32113\/ijmdat_20205_246 (2020).","DOI":"10.32113\/ijmdat_20205_246"},{"issue":"12","key":"23353_CR20","first-page":"95","volume":"14","author":"S Gogineni","year":"2015","unstructured":"Gogineni, S. & Vemulapalli, P. Comparative study of parenteral iron sucrose vs. oral ferrous ascorbate for prophylactic iron therapy in pregnancy. IOSR J. Dent. Med. Sci. 14 (12), 95\u201397 (2015). https:\/\/www.iosrjournals.org","journal-title":"IOSR J. Dent. Med. Sci."},{"key":"23353_CR21","doi-asserted-by":"publisher","first-page":"836","DOI":"10.18203\/2349-3933.ijam20233567","volume":"10","author":"P Kulkarni","year":"2023","unstructured":"Kulkarni, P. & Menon, S. A randomised open-label study to compare iron content in the blood of healthy subjects treated with Tasiron tablets containing ferric di-phosphate as compared to tablets containing ferrous ascorbate. Int. J. Adv. Med. 10, 836\u2013839 (2023).","journal-title":"Int. J. Adv. Med."},{"issue":"4","key":"23353_CR22","doi-asserted-by":"publisher","first-page":"496","DOI":"10.2478\/jomb-2018-0052","volume":"38","author":"MA U\u00e7ar","year":"2019","unstructured":"U\u00e7ar, M. A. et al. The importance of RET-He in the diagnosis of iron deficiency and iron deficiency anemia and the evaluation of response to oral iron therapy. J. Med. Biochem. 38 (4), 496\u2013502. https:\/\/doi.org\/10.2478\/jomb-2018-0052 (2019).","journal-title":"J. Med. Biochem."},{"issue":"1","key":"23353_CR23","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.htct.2021.05.006","volume":"45","author":"SD B\u00f3","year":"2023","unstructured":"B\u00f3, S. D., Fragoso, A. L. R., Farias, M. G., Hubner, D. P. G. & de Castro, S. M. Evaluation of RET-He values as an early indicator of iron deficiency anemia in pregnant women. Hematol. Transfus. Cell. Ther. 45 (1), 52\u201357. https:\/\/doi.org\/10.1016\/j.htct.2021.05.006 (2023). Epub 2021 Jul 2.","journal-title":"Hematol. Transfus. Cell. Ther."},{"issue":"4","key":"23353_CR24","doi-asserted-by":"publisher","first-page":"e24","DOI":"10.4081\/hr.2012.e24","volume":"4","author":"M Schoorl","year":"2012","unstructured":"Schoorl, M., Schoorl, M., van der Gaag, D. & Bartels, P. C. Effects of iron supplementation on red blood cell hemoglobin content in pregnancy. Hematol. Rep. 4 (4), e24. https:\/\/doi.org\/10.4081\/hr.2012.e24 (2012). Epub 2012 Nov 28.","journal-title":"Hematol. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23353-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23353-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23353-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T18:32:24Z","timestamp":1762972344000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23353-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,12]]},"references-count":24,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23353"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23353-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,12]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Dr. Alok S Shah and Dr. Ankita Srivastav are affiliated with Generex Pharmassist Pvt. Ltd. Dr. Ameet Patki, Dr. Vidya Thobbi, Dr. Jyothi G.S., and Dr. Gayatri Ganu declare no conflicts of interest. The authors affiliated with the manufacturer were not involved in the primary statistical analysis, and all data interpretation was conducted independently to minimize bias.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The informed consent was obtained from all participants before enrolment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"39671"}}